Friday 30th November 2018
Enhanced Liver Fibrosis Test: A new biomarker of fibrosis in systemic sclerosis
A multicentre study spread across Europe was recently conducted to evaluate how effective the Enhanced Liver Fibrosis (ELF) Test would be as a biomarker of fibrosis (scarring) in systemic sclerosis (SSc).This would aid the understanding of what drives fibrosis in individuals and thus enable the application of precision medicine for treatment strategies.